Abstract B056: Non-V600 BRAF mutations in melanoma: actionable targets for rational drug combinations
April A. N. Rose(Jewish General Hospital), Peter M. Siegel(L'Oréal (France)), Shivshankari Rajkumar(McGill University Health Centre), Kevin Petrecca(McGill University Health Centre), Matthew Dankner(McGill University), Catalin Mihalcioiu(McGill University Health Centre), Ian R. Watson(McGill University)
Cited by 1
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Intraoperative brain cancer detection with Raman spectroscopy in humans
|Science Translational Medicine|2015|625
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
|Nature Communications|2020|601
MAFG-driven astrocytes promote CNS inflammation
|Nature|2020|510